Bristlecone Advisors’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.14M | Sell |
14,658
-704
| -5% | -$106K | 0.18% | 96 |
|
|
2025
Q2 | $2.4M | Sell |
15,362
-539
| -3% | -$85.5K | 0.2% | 87 |
|
|
2025
Q1 | $2.62M | Sell |
15,901
-216
| -1% | -$35.9K | 0.21% | 96 |
|
|
2024
Q4 | $2.63M | Sell |
16,117
-351
| -2% | -$62.8K | 0.21% | 92 |
|
|
2024
Q3 | $3.22M | Sell |
16,468
-21
| -0.1% | -$3.87K | 0.26% | 80 |
|
|
2024
Q2 | $2.86M | Sell |
16,489
-589
| -3% | -$98K | 0.24% | 82 |
|
|
2024
Q1 | $2.89M | Sell |
17,078
-171
| -1% | -$32K | 0.25% | 81 |
|
|
2023
Q4 | $3.4M | Sell |
17,249
-190
| -1% | -$33.6K | 0.34% | 61 |
|
|
2023
Q3 | $3.03M | Buy |
17,439
+704
| +4% | +$128K | 0.34% | 62 |
|
|
2023
Q2 | $2.88M | Sell |
16,735
-723
| -4% | -$125K | 0.29% | 65 |
|
|
2023
Q1 | $2.91M | Sell |
17,458
-103
| -0.6% | -$16.9K | 0.32% | 61 |
|
|
2022
Q4 | $2.57M | Sell |
17,561
-302
| -2% | -$44.7K | 0.32% | 69 |
|
|
2022
Q3 | $2.65M | Buy |
17,863
+26
| +0.1% | +$4.34K | 0.35% | 61 |
|
|
2022
Q2 | $3.07M | Buy |
17,837
+65
| +0.4% | +$11.2K | 0.38% | 54 |
|
|
2022
Q1 | $3.35M | Sell |
17,772
-327
| -2% | -$64.6K | 0.41% | 51 |
|
|
2021
Q4 | $4.42M | Sell |
18,099
-1,960
| -10% | -$429K | 0.53% | 42 |
|
|
2021
Q3 | $3.89M | Sell |
20,059
-320
| -2% | -$64.6K | 0.51% | 46 |
|
|
2021
Q2 | $3.8M | Sell |
20,379
-281
| -1% | -$48.8K | 0.51% | 46 |
|
|
2021
Q1 | $3.25M | Sell |
20,660
-267
| -1% | -$42.3K | 0.49% | 51 |
|
|
2020
Q4 | $3.46M | Buy |
20,927
+52
| +0.2% | +$8.46K | 0.55% | 43 |
|
|
2020
Q3 | $3.45M | Sell |
20,875
-2,302
| -10% | -$354K | 0.63% | 40 |
|
|
2020
Q2 | $3.18M | Buy |
23,177
+1,503
| +7% | +$196K | 0.64% | 36 |
|
|
2020
Q1 | $2.55M | Buy |
21,674
+533
| +3% | +$70.2K | 0.61% | 39 |
|
|
2019
Q4 | $2.8M | Buy |
21,141
+860
| +4% | +$107K | 0.56% | 53 |
|
|
2019
Q3 | $2.53M | Sell |
20,281
-555
| -3% | -$67K | 0.62% | 51 |
|
|
2019
Q2 | $2.37M | Buy |
20,836
+1,545
| +8% | +$162K | 0.56% | 52 |
|
|
2019
Q1 | $1.94M | Buy |
19,291
+210
| +1% | +$19.1K | 0.54% | 56 |
|
|
2018
Q4 | $1.63M | Sell |
19,081
-95
| -0.5% | -$8.56K | 0.49% | 67 |
|
|
2018
Q3 | $1.76M | Buy |
19,176
+7,915
| +70% | +$702K | 0.44% | 68 |
|
|
2018
Q2 | $959K | Buy |
11,261
+465
| +4% | +$39.3K | 0.32% | 78 |
|
|
2018
Q1 | $902K | Sell |
10,796
-2,620
| -20% | -$206K | 0.3% | 82 |
|
|
2017
Q4 | $966K | Buy |
13,416
+13,375
| +32,622% | +$919K | 0.31% | 84 |
|
|
2017
Q3 | $3K | Buy |
+41
| New | +$2.57K | ﹤0.01% | 278 |
|
Other funds holding ZTS
Bristlecone Advisors's ZTS Position: Q3 2025 in Review
Bristlecone Advisors reduced its Zoetis (ZTS) stake by 4.6% in Q3 2025, selling an estimated $106K and leaving 14,658 shares worth $2.14M. The position accounts for 0.18% of the portfolio, ranked #96.
Bristlecone Advisors first reported a position in ZTS in Q3 2017 and has held it in 33 quarters since. The position peaked at $4.42M in Q4 2021. 1,799 funds tracked by Wall St. Rank hold ZTS as of Q3 2025.
- Bristlecone Advisors held 14,658 shares of Zoetis worth $2.14M as of Q3 2025.
- Bristlecone Advisors sold 704 Zoetis shares in Q3 2025, an estimated $106K.
- Zoetis made up 0.18% of Bristlecone Advisors's portfolio in Q3 2025, its #96 holding.
- Bristlecone Advisors first reported a position in Zoetis in Q3 2017 and has held it in 33 quarters since.
- Bristlecone Advisors's Zoetis position peaked at $4.42M in Q4 2021.
- 1,799 funds tracked by Wall St. Rank held Zoetis as of Q3 2025.
Based on Bristlecone Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.